Sclerosing peritonitis;Les péritonites encapsulantes

Journal de Chirurgie

Volumn 142, Issue 2, 2005, Pages 78-84

  Dutranoy, J C ^a,b   Molle, G ^a  

^a Hospital de Jolimont   (Belgium)

^b NONE   (Belgium)

Author keywords

Chronic obstruction; Diagnosis; Malnutrition; Sclerosing peritonitis; Treatment

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

ASCITES; CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HISTOLOGY; HUMAN; IMAGING; INTESTINE PERFUSION; NEPHROLOGY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; RADIODENSITOMETRY; RADIODIAGNOSIS; REVIEW; SCLEROSING PERITONITIS; SMALL INTESTINE OBSTRUCTION; SURGEON; SURGICAL TECHNIQUE;

EID: 19844378475     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0021-7697(05)80854-3     Document Type: Review

References (69)

1. Josa L. Sur la péritonite chronique fibreuse encapsulante Zentralblatt fur Chirurgie. 1927;27:1689-94
2. In J Chir 1927;30:600.
3. Wilmoth P, Patel J. La péritonite chronique encapsulante. J Chir 1931;37:341-357.
4. Deeb LS, Mourad FH, El-Zein YR, Uthman SM. Abdominal cocoon in a man: preoperative diagnosis and literature review. J Clin Gastrœnterol 1998;26:148-150.
5. Smith L, Collins JF, Morris M, Teele RL. Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: surgical management. Am J Kidney Dis 1997;29:456-460.
6. Niaudet P, Berard E, Revillon Y, Lothon, M, Broyer M. Sclerosing encapsulating peritonitis in children. Contr Nephrol 1987;57:230-238.
7. Sahoo SP, Gangopadhyay AN, Gupta DK, Gopal SC, Sharma SP, Dash RN. Abdominal cocoon in children: a report of four cases. J Pediatr Surg 1996;31:987-988.
8. Rottembourg J, Ghal GM, Poignet JL et al. Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis Proc Eur Dial Transpl Assoc 1983;20:236-242.
9. Carbonnel F, Barrie F, Beagerie L et al. Péritonite encapsulante. Une série de 10 observations et revue de la litterature. Gastrœnterol Clin Biol 1995;19:876-882.
10. Vegnaduzzo V. Une pérívíscérite diffuse: exceptionnelle association d'une péritonite encapsulante et d'un foie glacé ; Thèse Lille 1990.
11. Germain M.A, Misserey D, Dupouet L, Hureau J. Les péritonites encapsulantes; étiologies, traitements actuels. Chirurgie 1988;114:199-206.
12. Michel C, Hufnagel G, Niang A et al. Péritonite sclérosante. Néphrologie 2001;22:141-148.
13. Stafford-Johnson DB, Wilson TE, Francis IR, Swa R. CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis. J Comput Assist Tomogr 1998;22:295-299.
14. Marshall AJ, Baddeley H, Barritt DW et al. Practolol peritonitis. A study of 16 cases and a surgery of bowel function in patients taking beta-adrenergic blockers. Q J Med 1977;46:135-149.
15. Narayanan R, Bhargava BN, Kabra SG, Sangal BC. Idiopathic sclerosing encapsulating peritonitis. Lancet 1989;2:127-129.
16. Slingeneyer A, Canaud B, Mourad G. Sclerosing peritonitis: late and severe complications of long term home peritoneal dialysis. Trans Am Soc Artif Inter Organs 1983;12:64(A).
17. Mori Y, Matsuo S, Sutoh H, Toriyama T, Kawahara H, Hotta N. A case of dialysis patient with sclerosing peritonitis successfully treated by coticosteroid therapy alone. Am J Kidney Dis 1997;30:275-278.
18. Klimopoulos S, Katsoulis IE, Margellos V, Nikolopoulou N. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis. J R Coll Surg Edinb 2002;47:485-490.
19. Wirnsberger GH, Ganser K, Domej W et al. Sclerosing encapsulating peritonitis: differential diagnosis to peritoneal encapsulation and abdominal cocoon. A case report. Z Gastrœnterol. 1992;30:534-537.
20. Slingerneyer A, Mion C, Mourad G, Canaud B, Fallers B, Beraud JJ. Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1983;29:633-638.
21. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Periton Dialisis Int 1992;12:14-27.
22. Greenlee HB, Stanley MM, Reinhardt GF, Chejfec G. Small bowel obstruction from compression and kinking of intestine by thickened peritoneum in cirrhotics with ascites treated with LeVeen shunt. Gastrœnterology 1979;76:1282(A).
23. Cudazzo E, Lucchini A, Puviani PP et al. Sclerosing peritonitis. A complication of LeVeen peritoneovenous shunt. Minerva Chir 1999;54:809-812.
24. LaFerla G, McColl KEL, Crean GP. CSF induced sclerosing peritontis: a new entity? Br J Surg 1986;73:7.
25. Castelli MJ, Armin AR, Hussain A, Orfei E. Fibrosing peritonitis in a drug abuser. Arch Pathol Lab Med 1985;109:767-769.
26. Aihara H, Maruoka H, Kiyozaki H, Konishi F. Sclerosing encapsulating peritonitis as delayed complication of continuous hyperthermic peritoneal perfusion: report of a case. Surg Today 2003;33:232-236.
27. Atiq OT, Kelsen DP, Shiu MH et al. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425-433.
28. Keating JP, Neill M, Hill GL. Sclerosing encapsulating peritonitis after intraperitoneal use of povidone iodine. Aust NZ J Surg 1997;67:742-744.
29. Jenkins SB, Leng BL, Shortland JR, Brown PW, Wilkie ME. Sclerosing encapsulating peritonitis: a case series from a single U.K. center during a 10 - year period. Adv Pent Dial 2001;17:191-195.
30. Rigby RJ, Hawley CM. Sclerosing peritonitis: The experience in Australia. Nephrol Dial Transplant 1998;13:154-159.
31. Slingeneyer A. Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis. Contrib Nephrol 1987;57:239-247.
32. Oulès R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988;3:66-69.
33. Lo WK, Chan KT, Leung AC, Pang SW, Tse CY. Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connect procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991;11:166-172.
34. Mackow RC, Winchester JF, Argy WP et al. Sclerosing encapsulating peritonitis in rats: an experimental study with intraperitoneal antiseptics. Contr Nephrol 1987;57:213-218.
35. Verger C, Celicout B. Peritoneal permeability and encapsulating peritonitis. Lancet 1985;i:986-987.
36. McLaughlin K, Butt G, Madi A, McMillan M, Mactier R. Sclerosing peritonitis occurring in a hemodialysis patient. Am J Kidney Dis 1996;27:729-732.
37. Delefortrie M. À propos d'un cas de péritonite encapsulante. Thèse médecine, Montpellier, 1983.
38. Cosh J, Cates JE, Pugh DW. Carcinoid heart disease. Br Heart J 1959;21:369-380.
39. Jacob H, Brandt LJ, Farkas P, Frishman W. Beta-adrenergic blockade and the gastrointestinal system. Am J Med 1983;74:1042-1051.
40. Brown P, Baddeley H, Read AE et al. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic blocking drug (practolol). Lancet 1974;2:1477-1481.
41. Eltringham WK, Espiner HJ, Windsor CW et al. Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management. Br J Surg 1977;64:229-235.
42. Panting AL, Denham HE. Drug-induced sclerosing peritonitis. N Z Med J 1977;12(85):10-12.
43. Moss J, Berg RA, Baum BJ, Crystal RG. In vitro model for fibrosis induced by beta-adrenergic blockers: propanolol inhibits beta-adrenergic suppression of collagen production by human fibroblasts. Clin Res 1979;27:445(A).
44. Ngô Y, Messing B, Marteau P et al. Peritoneal sarcoïdosis: an unrecognised cause of sclerosing peritonitis. Dig Dis Sci 1992;37:1776-1780.
45. Githeko AK, McFarlane GA. Abdominal cocoon: report of five cases. East Afr Med J 2000;77:286-288.
46. Sieck JO, Cowgill R, Larkworthy W. Peritoneal encapsulation and abdominal cocoon: case reports and a review of the litterature. Gastrœnterology 1983;84:1597-1601.
47. Zantut LF, Birolini D. Emergency laparoscopy in patients submitted to abdominal surgery: a study of 20 cases. Rev Hosp Clin Fac Med Sao Paulo 1991;46:226-228.
48. Vorhauer W, Brière J, Passa P, Charleux H, Chelloul N. Péritonite encapsulante révélatrice d'un adénocarcinome gastrique. Sem Hop Paris 1976;52:1715-1718.
49. Soupault R. Au dossier de la péritonite encapsulante, les tumeurs de l'ovaire comme facteur d'étiologie. Presse Med 1943;51:116.
50. Albot G, Parturier-Albot F, Rettori R, Camilleri JP, Veyne S, Christofle J. Du rôle de la jéjuno-iléite diffuse dans la genèse de la péritonite encapsulante. Ann Gastrœnterol Hepatol 1970;6:1-17.
51. Bellin MF, Deutsch JP, Blétry O et al. Péritonite encapsulante au cours de la maladie périodique. Sem Hop Paris 1990;66:510-512.
52. Andrion A, Pira E, Mollo F. Peritoneal plaques and asbestos exposure. Arch Pathol Lab Med 1983;107:609-610.
53. Junor BJ, McMillan MA. Immunosuppression in sclerosing peritonitis. Adv Perit Dial 1993;9:187-189.
54. Dequanter D, Lefebvre JC, De Pauw L, Nortier J, Kinnaert P. Sclerosing peritonitis: report of three cases. Acta Chir Belg 2003;103:408-411.
55. Hawley C, Wall D, Johnson D. Recovery of gastrointestinal function following renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1995;26:658-661.
56. Martins, Rodrigues AS, Cabrita AN, Guimaraes S. Sclerosing encapsulating peritonitis: A case successfully treated with immunosuppression. Perit Dial Int 1999;19:478-490.
57. Bandhari S, Wilkinson A, Sellars L. Sclerosing peritonitis: value of immunosuppression prior to surgery. Nephrol Dial Transplant 1997;9:436-437.
58. Kawanishi H, Harada Y, Noriyuki T et al. Treatment options for encapsulating peritoneal sclerosis based on progressive stage. Adv Perit Dial 2001;17:200-204.
59. Pusateri R, Ross R, Marshall R, Meredith JH, Hamilton RW. Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature. Am J Kidney Dis 1986;8:56-60.
60. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999;55:341-356.
61. Hendriks PMEM, Ho-dac-Pannekeet MM, Van Gulik TM et al. Peritoneal sclerosis in peritoneal dialysis patients: analysis of clinical presentation, risk factors and peritoneal transport kinetics. Perit Dial Int 1997;136-143.
62. Selgas R, Bajo MA, Paiva A et al. Stability of the peritoneal membrane in long-term peritoneal dialysis patients. Adv Ren Replace Ther 1998;5:168-178.
63. Rottembourg J, Issad B, Langlois P et al. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD. Evaluation of the potential risk factors. Adv Perit Dial 1985;1:109-117.
64. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999;12:395-397.
65. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg 1990;125:1626-1628.
66. Germain M.A, Dupouet L. Péritonites encapsulantes. E MC Paris. Estomac, Intestin. 1988,9045 A 10.
67. Celicout B, Levard H, Hay J, Msika S, Fingerhut A, Pelissier E. Sclerosing encapsulating peritonitis: early and late results of surgical treatment in 32 cases. Dig Surg 1998;15:697-702.
68. Yamamoto T, Izumotani T, Otoshi T, Kim M. Morphological studies of mesothelial cells in CAPD effluent and their clinical significance. Am J Kidney Dis 1998;32:946-952.
69. Ishii Y, Sawada T, Shimizu A et al. An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 2001;16:1262-1266.